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Background: The association between gallstones and abnormal lipids and later increase in risk of coro-
nary artery disease and stroke has been shown in many studies. The aim of study is to elucidate the
association of dyslipidaemia with Cholilithiasis and effect of Cholecystectomy on the same.
Methods: 73 patients with symptomatic gallstones were studied prospectively. Plasma concentration of
cholesterol, triglycerides, LDL, HDL was analysed preoperatively and postoperatively on day 3 and after 6
months of Cholecystectomy. None of the patients received any lipid lowering drug or dietary restriction.
Results were analysed and compared.
Results: 36 (80%) of the female patients and 20 (71.42%) of male patients had one or other abnormality in
their lipid proﬁle preoperatively Plasma concentration of total cholesterol, triglycerides, and LDL
cholesterol were signiﬁcantly reduced in patients on day 3 of surgery and 6 months thereafter. There was
no signiﬁcant increase/decrease in HDL cholesterol in 6 months after Cholecystectomy.
Conclusion: There was a signiﬁcant decrease in plasma concentration of lipids in Cholecystectomy
patients postoperatively. These changes in plasma lipids are likely to have signiﬁcant effect in the
development of coronary artery diseases in patients with Cholecystectomy.
 2011 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Gallstones are the most common biliary pathology. In 1992, it
was estimated that 10e15% of adult population in USA had gall-
stones (20 million people) and 600,000 underwent cholecystec-
tomy annually. Patients of renal stones are most often evaluated for
any underlying metabolic disorder but the same is not an estab-
lished practice in gall stone patients. The movement of cholesterol
from the liver into the bile must be accompanied by the simulta-
neous secretion of phospholipid and bile salts. If this dual process is
disrupted and more cholesterol enters the bile than can be solu-
bilised by bile salts and lecithin present, the cholesterol may
precipitate in the gall bladder, initiating the occurrence of choles-
terol gallstone disease. This disorder is typically caused by decrease
of bile acids in the bile, which may result from:
 Gross malabsorption of bile acids from intestine.
 Obstruction of biliary tract.
 Severe hepatic dysfunction leading to decreased synthesis of
bile salts
 Excessive feedback suppression of bile acid synthesis.mohdlateef@gmail.com (M.
ciates Ltd. Published by Elsevier LtEvidence from 30 years ago show that about half of patients
with gallstones will have an abnormal lipid proﬁle.1 This would
increase their risk of coronary artery disease and stroke.2e8 There is
no Indian or UK data on which to base our current practice. This
study prospectively investigates the frequency of lipid disorder in
patients of cholilithiasis and effect of Cholecystectomy on the same.
2. Methods
73 patients of symptomatic cholilithiasis (Ultrasonography documented) were
studiedprospectively. Thesepatientswere evaluated inouroutpatient department. All
patients underwent detailed history and clinical examination. Base line investigations
included Haemogram, Kidney function, Liver function, Electrocardiography and X-ray
chest. Adetailed lipidproﬁle (serumcholesterol, triglycerides, LDLcholesterol andHDL
cholesterol) of all these patients was obtained preoperatively. All the patients under-
went pre-anaesthetic check up by an anaesthetist. All these patients underwent
Laparoscopic Cholecystectomy subsequently for symptomatic cholilithiasis. Another
detailed lipid proﬁle was obtained on day 3rd of surgery. Patients were followed for 6
months and a lipid proﬁle at 6months postoperatively was also obtained. None of the
patients was put on any lipid lowering drug or any dietary restriction.
3. Results
Of the 73 Cholecystectomies performed 45 (61.64%) were
females and 28(38.35%) were males. Median age of females was 38
years (range 18e67 years) and 42 years for males (20e72 years). All
patients underwent lipid proﬁle in the main laboratory of ourd. All rights reserved.
Table 1
Preoperative lipid proﬁle of patients.
Lipids Female Male
Cholesterol > 5 mmol/L 36/45(80%) 20/28(71.42%)
Triglycerides > 1.92 mmol/L 20/45(44.4%) 11/28(39.28%)
HDL Cholesterol < 1 mmol/L 5/45(11.11%) 5/28(17.85%)
LDL Cholesterol > 3 mmol/L 10/45(22.22%) 3/28(10.71%)
Hypercholesterolemia was the most common abnormality followed by
hypertriglyceremia.
Table 3
Lipid proﬁle at 6 months after surgery (Cholecystectomy).
Lipids Female P-value Male P-value
Cholesterol > 5 mmol/L 8/45(17.77%) 0.179 6/28(21.42%) 0.141
Triglycerides > 1.92 mmol/L 3/45(6.66%) 1.000 2/28(7.14%) 0.146
HDL Cholesterol < 1 mmol/L 5/45(11.11%) 0.000 5/28(17.85%) 0.000
LDL Cholesterol > 3 mmol/L 3/45(6.66%) 0.008 2/28(7.14%) 0.008
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ORIGINAL RESEARCHHospital (SKIMS). 36 (80%) of the female patients and 20 (71.42%) of
male patients had one or other abnormality in their lipid proﬁle
preoperatively. Cholesterol was raised in 80% of the females and
71.42% of male patients. Triglycerides were raised in 44.4% of
female patients and 39.28% of male patients. HDL Cholesterol was
abnormal in 11.11% of female patients and 17.85% of female patients.
Similarly LDL cholesterol was abnormal in 22.2% of female patients
and 10.7% of female patients (Table 1). All these patients underwent
lipid proﬁle on day third of surgery. There was an improvement in
lipid proﬁle abnormality (Table 2). Only 18 (40%) of the female
patients and 13 (46.42%) of male patients had one or the other
abnormality in lipid proﬁle. Cholesterol was raised in 40% of female
patients (P value 0.007) and 46.42% ofmale patients (P value 0.002).
Triglycerides were abnormal in 13.33% of female patients (P value
0.005) and 28.57% of male patients (P Value 0.05). Patients under-
went 3rd lipid proﬁle after 6 months of surgery. There was again
improvement in lipid proﬁle of the patients. Only 3(15%) of the
female patients and 3 (23%) of male patients had one or the other
abnormality in lipid proﬁle (Table 3).
4. Disscusion
Most of the patients with gallstones are not evaluated for any
metabolic disorder. Allmost abouthalf of patientswith gallstoneswill
have an abnormal lipid proﬁle.1 In United Kingdom about 5.5 million
people have gallstones and around 50,000 Cholecystectomy are per-
formed eachyear. 9Bile is the only signiﬁcant pathway for elimination
of excess cholesterol fromthe body, either as free cholesterol or asbile
salts. Cholesterol is water insoluble and is rendered water soluble by
aggregation with bile salts and lecithin cosecreted into bile. When
cholesterol concentration exceeds the solubilising capacity of bile,
cholesterol can no longer remain dispersed and nucleates into the
solid cholesterol monohydrate crystals. Three conditions must
therefore bemet to permit the formation of cholesterol gallstones:(1)
Bile must be supersaturated with cholesterol, (2) Nucleationmust be
kinetically favourable, (3) Cholesterol crystalsmust remain in the gall
bladder longenough to aggregate into stones.Nucleation is promoted
bymicro precipitated of inorganic or organic calcium salts, serving as
nucleation sites for cholesterol stones. Gall bladder stasis plays a key
role inpermitting stone formation and growth. As bile becomesmore
concentrated during storage in gall bladder, cholesterol saturation of
bile also may further increase. Since around half of the patients of
cholilithiasis have abnormal lipid proﬁle this would increase the
incidence of coronary artery disease and stroke.2e8 Recent European
studies have shown that hypertriglyceridaemia, hypercholesterol-
emia and low level of high density lipoprotein cholesterol(HDL)Table 2
Lipid proﬁle on day 3rd of surgery (Cholecystectomy).
Lipids Female P-Value Male P-value
Cholesterol > 5 mmol/L 18/45(40%) 0.007 13/28(46.42%) 0.002
Triglycerides > 1.92 mmol/L 6/45(13.33%) 0.005 8/28(28.57%) 0.050
HDL Cholesterol < 1 mmol/L 5/45(11.11%) 0.000 5/28(17.85%) 0.000
LDL Cholesterol > 3 mmol/L 8/45(17.77%) 0.000 2/28(7.14%) 0.008
There was a signiﬁcant decrease in lipid proﬁle abnormalities on 3rd postoperative
Day.a common ﬁnding in patients with cholilithiasis.10,11 It is well known
that this in turn will be a risk factor for coronary artery disease and
stroke.12e14 Around 80% of women and 70% of men in our study had
abnormal lipid proﬁle preoperatively. Hypercholesterolemia was the
most common abnormality in both the sexes followed by hyper-
triglyceridaemia. This incidence decreased on the day 3rd of surgery.
Micheal J.,Walmsley j., andPhilipFSchoﬁeldhadsimilar result inearly
postoperative period,15 similar results were also achieved by Juvonen
etal.16Thisobservationwasprobablybecauseofalteredenterohepatic
circulation. All our patients were followed for six months and there
was a decrease in incidence of abnormal lipid proﬁle at 6 months
postoperatively again. This observation was in contrast to other
series.15,16 Our series is the ﬁrst series to observe such result.
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